|
Market Closed -
Euronext Dublin
11:55:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | 0.00% |
|
0.00% | -9.09% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 30.35M 34.53M 28.58M 26.12M 48.82M 3.31B 49.23M 343M 133M 1.69B 130M 127M 5.48B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.45M 19.85M 16.43M 15.02M 28.06M 1.9B 28.3M 197M 76.43M 971M 74.51M 72.89M 3.15B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -5.41% | ||
| 6 months | -9.09% | ||
| Current year | -9.09% |
| 1 week | 6.8 |  | 7 |
| 1 month | 6.8 | | 7 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 13.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 2019-08-01 |
| Director/Board Member | 67 | 2018-07-15 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 2018-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/26 | Exercice | 10,307 | 0.2382% | |||
| 5/28/25 | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -14.63% | +54.19% | 34.57M | |
| +2.68% | +3.87% | +58.22% | +114.68% | 1,026B | |
| +0.56% | +1.27% | +53.29% | +68.65% | 649B | |
| +0.02% | +0.99% | +19.10% | +73.58% | 468B | |
| +0.06% | +0.25% | +37.03% | +45.71% | 352B | |
| +1.16% | +4.10% | +21.99% | +29.39% | 271B | |
| -0.24% | +2.18% | +10.14% | +12.26% | 256B | |
| -0.01% | +7.89% | +41.57% | +51.68% | 220B | |
| -1.11% | +1.36% | +30.85% | +99.56% | 188B | |
| +0.30% | -7.19% | -32.43% | -60.56% | 170B | |
| Average | +0.07% | +1.13% | +22.51% | +48.91% | 359.91B | |
| Weighted average by Cap. | +0.13% | +1.26% | +37.30% | +67.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.85M -6.5M -5.94M -11.1M -753M -11.19M -77.88M -30.23M -384M -29.47M -28.83M -1.25B |
| Net Debt | -62.1M -70.66M -58.5M -53.46M -99.9M -6.78B -101M -701M -272M -3.46B -265M -259M -11.22B | -12.9M -14.68M -12.15M -11.1M -20.75M -1.41B -20.93M -146M -56.52M -718M -55.1M -53.9M -2.33B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | €7.000 | 0.00% | 0 |
| 26-09-23 | €7.000 | 0.00% | 0 |
| 26-09-22 | €7.000 | +2.94% | 1 |
| 26-09-21 | €6.800 | 0.00% | 26 |
| 26-09-18 | €6.800 | -2.86% | 141 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.000EUR
Average target price
15.50EUR
Spread / Average Target
+121.43%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
